General Information of the m6A Target Gene (ID: M6ATAR00199)
Target Name Brain and muscle ARNT-like 1 (Bmal1/ARNTL)
Synonyms
Basic-helix-loop-helix-PAS protein MOP3; Brain and muscle ARNT-like 1; Class E basic helix-loop-helix protein 5; bHLHe5; Member of PAS protein 3; PAS domain-containing protein 3; bHLH-PAS protein JAP3; BHLHE5; BMAL1; MOP3; PASD3
    Click to Show/Hide
Gene Name ARNTL
Chromosomal Location 11p15.3
Function
Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. ARNTL/BMAL1 positively regulates myogenesis and negatively regulates adipogenesis via the transcriptional control of the genes of the canonical Wnt signaling pathway. Plays a role in normal pancreatic beta-cell function; regulates glucose-stimulated insulin secretion via the regulation of antioxidant genes NFE2L2/NRF2 and its targets SESN2, PRDX3, CCLC and CCLM. Negatively regulates the mTORC1 signaling pathway; regulates the expression of MTOR and DEPTOR. Controls diurnal oscillations of Ly6C inflammatory monocytes; rhythmic recruitment of the PRC2 complex imparts diurnal variation to chemokine expression that is necessary to sustain Ly6C monocyte rhythms. Regulates the expression of HSD3B2, STAR, PTGS2, CYP11A1, CYP19A1 and LHCGR in the ovary and also the genes involved in hair growth. Plays an important role in adult hippocampal neurogenesis by regulating the timely entry of neural stem/progenitor cells (NSPCs) into the cell cycle and the number of cell divisions that take place prior to cell-cycle exit. Regulates the circadian expression of CIART and KLF11. The CLOCK-ARNTL/BMAL1 heterodimer regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes implicated in glucose and lipid metabolism. Promotes rhythmic chromatin opening, regulating the DNA accessibility of other transcription factors. The NPAS2-ARNTL/BMAL1 heterodimer positively regulates the expression of MAOA, F7 and LDHA and modulates the circadian rhythm of daytime contrast sensitivity by regulating the rhythmic expression of adenylate cyclase type 1 (ADCY1) in the retina. The preferred binding motif for the CLOCK-ARNTL/BMAL1 heterodimer is 5'-CACGTGA-3', which contains a flanking Ala residue in addition to the canonical 6-nucleotide E-box sequence. CLOCK specifically binds to the half-site 5'-CAC-3', while ARNTL binds to the half-site 5'-GTGA-3'. The CLOCK-ARNTL/BMAL1 heterodimer also recognizes the non-canonical E-box motifs 5'-AACGTGA-3' and 5'-CATGTGA-3'. Essential for the rhythmic interaction of CLOCK with ASS1 and plays a critical role in positively regulating CLOCK-mediated acetylation of ASS1. Plays a role in protecting against lethal sepsis by limiting the expression of immune checkpoint protein CD274 in macrophages in a PKM2-dependent manner (By similarity). Regulates the diurnal rhythms of skeletal muscle metabolism via transcriptional activation of genes promoting triglyceride synthesis (DGAT2) and metabolic efficiency (COQ10B) (By similarity). (Microbial infection) Regulates SARS coronavirus-2/SARS-CoV-2 entry and replication in lung epithelial cells probably through the post-transcriptional regulation of ACE2 and interferon-stimulated gene expression.
    Click to Show/Hide
Gene ID 406
Uniprot ID
BMAL1_HUMAN
HGNC ID
HGNC:701
KEGG ID
hsa:406
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ARNTL can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3
Cell Line mouse embryonic stem cells Mus musculus
Treatment: METTL3-/- ESCs
Control: Wild type ESCs
GSE145309
Regulation
logFC: -1.11E+00
p-value: 1.53E-46
More Results Click to View More RNA-seq Results
In total 2 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Hepatic deletion of Brain and muscle ARNT-like 1 (Bmal1/ARNTL) increases m6A mRNA methylation, particularly of PPaRalpha. Inhibition of m6A methylation via knockdown of m6A methyltransferase METTL3 decreases PPaR-Alpha m6A abundance and increases PPaRalpha mRNA lifetime and expression, reducing lipid accumulation in cells in vitro. YTHDF2 binds to PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Transcriptional regulation of circadian rhythms is essential for lipid metabolic homeostasis, disruptions of which can lead to metabolic diseases.
Target Regulation Up regulation
Responsed Disease Metabolic disorders ICD-11: 5D2Z
Pathway Response Adipocytokine signaling pathway hsa04920
Cell Process Llipid metabolism
In-vitro Model Hep-G2 Hepatoblastoma Homo sapiens CVCL_0027
Hepa 1-6 Hepatocellular carcinoma of the mouse Mus musculus CVCL_0327
In-vivo Model Liver-specific Bmal1f/f-AlbCre-knockout mice were purchased from Jackson Laboratory. C57BI/6J or Bmal1f/f-AlbCre-knockout male mice were maintained under a 12 hr light/12 hr dark (LD) cycle (ZT0 = 6 AM) and fed ad libitum with normal rodent chow (2018 Global 18% Protein diet, Envigo) and water. At 10-14 weeks of age, 10 male mice per group were sacrificed via CO2 asphyxiation at Zeitgeber Time (ZT) 0,2,6,10,12,14,18,22. In order to induce high levels of ROS in the liver, WT male mice were fasted 12 h and followed by intraperitoneal injection with 300 mg/kg APAP dissolved in PBS and re-fed.
Experiment 2 Reporting the m6A Methylation Regulator of This Target Gene [2]
Response Summary Liver-specific Mettl3 knockout mice exhibited global decrease in m6A on polyadenylated RNAs and pathologic features associated with nonalcoholic fatty liver disease. Studies in the M3LKO model indicated that METTL3 exhibits pleotropic function to maintain liver homeostasis by deregulating m6A profile and expression of the liver transcriptome. A significant decrease in total Brain and muscle ARNT-like 1 (Bmal1/ARNTL) and Clock mRNAs but an increase in their nuclear levels were observed in M3LKO livers, suggesting impaired nuclear export.
Target Regulation Up regulation
Responsed Disease Non-alcoholic fatty liver disease ICD-11: DB92
In-vivo Model M3LKO (Mettl3fl/fl; Alb-Cre) mice were generated by crossing Mettl3fl/fl mice (provided by Dr. Jacob Hanna) with albumin-Cre mice (Jackson Laboratories, Bar Harbor, ME), and genotypes were confirmed by tail-DNA PCR using primers as previously described.
YTH domain-containing family protein 2 (YTHDF2) [READER]
Representative RNA-seq result indicating the expression of this target gene regulated by YTHDF2
Cell Line B18-hi B cell line Mus musculus
Treatment: YTHDF2 knockout B18-hi B cells
Control: Wild type B18-hi B cells
GSE189819
Regulation
logFC: -7.97E-01
p-value: 5.55E-03
More Results Click to View More RNA-seq Results
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Hepatic deletion of Brain and muscle ARNT-like 1 (Bmal1/ARNTL) increases m6A mRNA methylation, particularly of PPaRalpha. Inhibition of m6A methylation via knockdown of m6A methyltransferase METTL3 decreases PPaR-Alpha m6A abundance and increases PPaRalpha mRNA lifetime and expression, reducing lipid accumulation in cells in vitro. YTHDF2 binds to PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Transcriptional regulation of circadian rhythms is essential for lipid metabolic homeostasis, disruptions of which can lead to metabolic diseases.
Target Regulation Down regulation
Responsed Disease Metabolic disorders ICD-11: 5D2Z
Pathway Response PPAR signaling pathway hsa03320
Adipocytokine signaling pathway hsa04920
Cell Process Llipid metabolism
In-vitro Model Hep-G2 Hepatoblastoma Homo sapiens CVCL_0027
Hepa 1-6 Hepatocellular carcinoma of the mouse Mus musculus CVCL_0327
In-vivo Model Liver-specific Bmal1f/f-AlbCre-knockout mice were purchased from Jackson Laboratory. C57BI/6J or Bmal1f/f-AlbCre-knockout male mice were maintained under a 12 hr light/12 hr dark (LD) cycle (ZT0 = 6 AM) and fed ad libitum with normal rodent chow (2018 Global 18% Protein diet, Envigo) and water. At 10-14 weeks of age, 10 male mice per group were sacrificed via CO2 asphyxiation at Zeitgeber Time (ZT) 0,2,6,10,12,14,18,22. In order to induce high levels of ROS in the liver, WT male mice were fasted 12 h and followed by intraperitoneal injection with 300 mg/kg APAP dissolved in PBS and re-fed.
Metabolic disorders [ICD-11: 5D2Z]
In total 2 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Hepatic deletion of Brain and muscle ARNT-like 1 (Bmal1/ARNTL) increases m6A mRNA methylation, particularly of PPaRalpha. Inhibition of m6A methylation via knockdown of m6A methyltransferase METTL3 decreases PPaR-Alpha m6A abundance and increases PPaRalpha mRNA lifetime and expression, reducing lipid accumulation in cells in vitro. YTHDF2 binds to PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Transcriptional regulation of circadian rhythms is essential for lipid metabolic homeostasis, disruptions of which can lead to metabolic diseases.
Responsed Disease Metabolic disorders [ICD-11: 5D2Z]
Target Regulator Methyltransferase-like 3 (METTL3) WRITER
Target Regulation Up regulation
Pathway Response Adipocytokine signaling pathway hsa04920
Cell Process Llipid metabolism
In-vitro Model Hep-G2 Hepatoblastoma Homo sapiens CVCL_0027
Hepa 1-6 Hepatocellular carcinoma of the mouse Mus musculus CVCL_0327
In-vivo Model Liver-specific Bmal1f/f-AlbCre-knockout mice were purchased from Jackson Laboratory. C57BI/6J or Bmal1f/f-AlbCre-knockout male mice were maintained under a 12 hr light/12 hr dark (LD) cycle (ZT0 = 6 AM) and fed ad libitum with normal rodent chow (2018 Global 18% Protein diet, Envigo) and water. At 10-14 weeks of age, 10 male mice per group were sacrificed via CO2 asphyxiation at Zeitgeber Time (ZT) 0,2,6,10,12,14,18,22. In order to induce high levels of ROS in the liver, WT male mice were fasted 12 h and followed by intraperitoneal injection with 300 mg/kg APAP dissolved in PBS and re-fed.
Experiment 2 Reporting the m6A-centered Disease Response [1]
Response Summary PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Hepatic deletion of Brain and muscle ARNT-like 1 (Bmal1/ARNTL) increases m6A mRNA methylation, particularly of PPaRalpha. Inhibition of m6A methylation via knockdown of m6A methyltransferase METTL3 decreases PPaR-Alpha m6A abundance and increases PPaRalpha mRNA lifetime and expression, reducing lipid accumulation in cells in vitro. YTHDF2 binds to PPaRalpha to mediate its mRNA stability to regulate lipid metabolism. Transcriptional regulation of circadian rhythms is essential for lipid metabolic homeostasis, disruptions of which can lead to metabolic diseases.
Responsed Disease Metabolic disorders [ICD-11: 5D2Z]
Target Regulator YTH domain-containing family protein 2 (YTHDF2) READER
Target Regulation Down regulation
Pathway Response PPAR signaling pathway hsa03320
Adipocytokine signaling pathway hsa04920
Cell Process Llipid metabolism
In-vitro Model Hep-G2 Hepatoblastoma Homo sapiens CVCL_0027
Hepa 1-6 Hepatocellular carcinoma of the mouse Mus musculus CVCL_0327
In-vivo Model Liver-specific Bmal1f/f-AlbCre-knockout mice were purchased from Jackson Laboratory. C57BI/6J or Bmal1f/f-AlbCre-knockout male mice were maintained under a 12 hr light/12 hr dark (LD) cycle (ZT0 = 6 AM) and fed ad libitum with normal rodent chow (2018 Global 18% Protein diet, Envigo) and water. At 10-14 weeks of age, 10 male mice per group were sacrificed via CO2 asphyxiation at Zeitgeber Time (ZT) 0,2,6,10,12,14,18,22. In order to induce high levels of ROS in the liver, WT male mice were fasted 12 h and followed by intraperitoneal injection with 300 mg/kg APAP dissolved in PBS and re-fed.
Non-alcoholic fatty liver disease [ICD-11: DB92]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [2]
Response Summary Liver-specific Mettl3 knockout mice exhibited global decrease in m6A on polyadenylated RNAs and pathologic features associated with nonalcoholic fatty liver disease. Studies in the M3LKO model indicated that METTL3 exhibits pleotropic function to maintain liver homeostasis by deregulating m6A profile and expression of the liver transcriptome. A significant decrease in total Brain and muscle ARNT-like 1 (Bmal1/ARNTL) and Clock mRNAs but an increase in their nuclear levels were observed in M3LKO livers, suggesting impaired nuclear export.
Responsed Disease Non-alcoholic fatty liver disease [ICD-11: DB92]
Target Regulator Methyltransferase-like 3 (METTL3) WRITER
Target Regulation Up regulation
In-vivo Model M3LKO (Mettl3fl/fl; Alb-Cre) mice were generated by crossing Mettl3fl/fl mice (provided by Dr. Jacob Hanna) with albumin-Cre mice (Jackson Laboratories, Bar Harbor, ME), and genotypes were confirmed by tail-DNA PCR using primers as previously described.
RNA Modification Sequencing Data Associated with the Target (ID: M6ATAR00199)
Brain and muscle ARNT-like 1 (Bmal1/ARNTL)
N6-methyladenosine (m6A)
In total 22 m6A sequence/site(s) in this target gene
mod ID: M6ASITE004206 Click to Show/Hide the Full List
mod site chr11:13277856-13277857:+ [3]
Sequence TGCCTGTTTACCCGCGCCGGACTCACCGCCGCCGCCGCCGC
Motif Score 4.065041667
Cell/Tissue List U2OS; HEK293A-TOA; TIME
Seq Type List MeRIP-seq; m6A-seq
Transcript ID List ENST00000529825.5; ENST00000403510.7; ENST00000533520.5; ENST00000534544.5; ENST00000389707.8; ENST00000529050.5; ENST00000527998.5; ENST00000529388.5; ENST00000403290.5; ENST00000480685.5; ENST00000401424.5; ENST00000530357.5
External Link RMBase: m6A_site_132518
mod ID: M6ASITE004207 Click to Show/Hide the Full List
mod site chr11:13310015-13310016:+ [3]
Sequence GCTAGAGTGTATACGTTTGGACCCAAGCTTAACTTTTCCAA
Motif Score 3.622404762
Cell/Tissue List U2OS; iSLK; TIME
Seq Type List MeRIP-seq
Transcript ID List ENST00000529825.5; ENST00000530357.5; ENST00000403290.5; ENST00000389707.8; ENST00000531665.5; ENST00000529388.5; ENST00000401424.5; ENST00000534544.5; ENST00000533520.5; ENST00000527998.5; ENST00000480685.5; ENST00000529050.5; ENST00000482049.5; ENST00000403510.7
External Link RMBase: m6A_site_132519
mod ID: M6ASITE004208 Click to Show/Hide the Full List
mod site chr11:13349984-13349985:+ [4]
Sequence GCCTGAAAAGAAATTATAAAACATGAAAATCGCTTTGAGGT
Motif Score 2.20572619
Cell/Tissue List hESC-HEK293T
Seq Type List MAZTER-seq
Transcript ID List ENST00000529825.5; ENST00000403290.5; ENST00000527998.5; ENST00000389707.8; ENST00000529050.5; ENST00000401424.5; ENST00000534544.5; ENST00000403510.7; ENST00000529388.5; ENST00000533520.5; ENST00000485918.2; ENST00000482049.5; ENST00000531665.5; ENST00000530357.5; ENST00000480685.5
External Link RMBase: m6A_site_132520
mod ID: M6ASITE004209 Click to Show/Hide the Full List
mod site chr11:13358581-13358582:+ [5]
Sequence TGGCTGTTCAGCACATGAAAACATTAAGAGGTGAGACCCTG
Motif Score 2.20572619
Cell/Tissue List Huh7
Seq Type List MeRIP-seq
Transcript ID List ENST00000401424.5; ENST00000389707.8; ENST00000403482.7; ENST00000403290.5; ENST00000497429.5; ENST00000403510.7; ENST00000530357.5; ENST00000529388.5
External Link RMBase: m6A_site_132521
mod ID: M6ASITE004210 Click to Show/Hide the Full List
mod site chr11:13360371-13360372:+ [5]
Sequence CAATCCATACACAGAAGCAAACTACAAACCAACTTTTCTAT
Motif Score 2.627720238
Cell/Tissue List Huh7
Seq Type List MeRIP-seq
Transcript ID List ENST00000529388.5; ENST00000401424.5; ENST00000403482.7; ENST00000530357.5; ENST00000389707.8; ENST00000403290.5; ENST00000497429.5; ENST00000403510.7
External Link RMBase: m6A_site_132522
mod ID: M6ASITE004211 Click to Show/Hide the Full List
mod site chr11:13360378-13360379:+ [5]
Sequence TACACAGAAGCAAACTACAAACCAACTTTTCTATCAGACGA
Motif Score 2.185083333
Cell/Tissue List Huh7
Seq Type List MeRIP-seq
Transcript ID List ENST00000403482.7; ENST00000403290.5; ENST00000530357.5; ENST00000389707.8; ENST00000497429.5; ENST00000401424.5; ENST00000403510.7
External Link RMBase: m6A_site_132523
mod ID: M6ASITE004212 Click to Show/Hide the Full List
mod site chr11:13372217-13372218:+ [6]
Sequence GGCTATTTGAAAAGCTGGCCACCCACAAAGATGGGGCTGGA
Motif Score 2.032470238
Cell/Tissue List HEK293T
Seq Type List DART-seq
Transcript ID List ENST00000389707.8; ENST00000403510.7; ENST00000403482.7; ENST00000401424.5; ENST00000529390.1; ENST00000403290.5; ENST00000497429.5
External Link RMBase: m6A_site_132524
mod ID: M6ASITE004213 Click to Show/Hide the Full List
mod site chr11:13372243-13372244:+ [6]
Sequence AAAGATGGGGCTGGATGAAGACAACGAACCAGACAATGAGG
Motif Score 2.897386905
Cell/Tissue List HEK293T; MT4
Seq Type List DART-seq; MeRIP-seq
Transcript ID List ENST00000401424.5; ENST00000403290.5; ENST00000529390.1; ENST00000389707.8; ENST00000403510.7; ENST00000497429.5; ENST00000403482.7
External Link RMBase: m6A_site_132525
mod ID: M6ASITE004214 Click to Show/Hide the Full List
mod site chr11:13372246-13372247:+ [6]
Sequence GATGGGGCTGGATGAAGACAACGAACCAGACAATGAGGGGT
Motif Score 2.147845238
Cell/Tissue List HEK293T
Seq Type List DART-seq
Transcript ID List ENST00000403290.5; ENST00000389707.8; ENST00000403482.7; ENST00000401424.5; ENST00000529390.1; ENST00000497429.5; ENST00000403510.7
External Link RMBase: m6A_site_132526
mod ID: M6ASITE004215 Click to Show/Hide the Full List
mod site chr11:13372250-13372251:+ [7]
Sequence GGGCTGGATGAAGACAACGAACCAGACAATGAGGGGTGTAA
Motif Score 2.930744048
Cell/Tissue List MT4
Seq Type List MeRIP-seq
Transcript ID List ENST00000529390.1; ENST00000497429.5; ENST00000403510.7; ENST00000403290.5; ENST00000403482.7; ENST00000401424.5; ENST00000389707.8
External Link RMBase: m6A_site_132527
mod ID: M6ASITE004216 Click to Show/Hide the Full List
mod site chr11:13372255-13372256:+ [4]
Sequence GGATGAAGACAACGAACCAGACAATGAGGGGTGTAACCTCA
Motif Score 2.897386905
Cell/Tissue List hESC-HEK293T
Seq Type List MAZTER-seq
Transcript ID List ENST00000403290.5; ENST00000403482.7; ENST00000389707.8; ENST00000403510.7; ENST00000401424.5; ENST00000497429.5; ENST00000529390.1
External Link RMBase: m6A_site_132528
mod ID: M6ASITE004217 Click to Show/Hide the Full List
mod site chr11:13372319-13372320:+ [4]
Sequence CTGCATTCTCATGTAGTTCCACAACCAGTGAACGGGGAAAT
Motif Score 2.053113095
Cell/Tissue List hESC-HEK293T
Seq Type List MAZTER-seq
Transcript ID List ENST00000403510.7; ENST00000529390.1; ENST00000389707.8; ENST00000497429.5; ENST00000401424.5; ENST00000403482.7; ENST00000403290.5
External Link RMBase: m6A_site_132529
mod ID: M6ASITE004218 Click to Show/Hide the Full List
mod site chr11:13374137-13374138:+ [8]
Sequence TACCACAAGAACTTCTAGGCACATCGTGTTATGAATATTTT
Motif Score 2.830589286
Cell/Tissue List brain
Seq Type List m6A-REF-seq
Transcript ID List ENST00000389707.8; ENST00000524392.5; ENST00000401424.5; ENST00000529390.1; ENST00000403290.5; ENST00000403482.7; ENST00000403510.7
External Link RMBase: m6A_site_132530
mod ID: M6ASITE004219 Click to Show/Hide the Full List
mod site chr11:13374168-13374169:+ [6]
Sequence TGAATATTTTCACCAAGATGACATAGGACATCTTGCAGAAT
Motif Score 2.859755952
Cell/Tissue List HEK293T
Seq Type List DART-seq
Transcript ID List ENST00000401424.5; ENST00000389707.8; ENST00000524392.5; ENST00000403482.7; ENST00000403290.5; ENST00000529390.1; ENST00000403510.7
External Link RMBase: m6A_site_132531
mod ID: M6ASITE004220 Click to Show/Hide the Full List
mod site chr11:13375679-13375680:+ [4]
Sequence TCAAAGATGGTTCTTTTATCACACTACGGAGTCGATGGTTC
Motif Score 2.047297619
Cell/Tissue List hESC-HEK293T
Seq Type List MAZTER-seq
Transcript ID List ENST00000472842.1; ENST00000524392.5; ENST00000403290.5; ENST00000403482.7; ENST00000403510.7; ENST00000389707.8; ENST00000529390.1; ENST00000401424.5
External Link RMBase: m6A_site_132532
mod ID: M6ASITE004221 Click to Show/Hide the Full List
mod site chr11:13375749-13375750:+ [4]
Sequence AGAATATATTGTCTCAACTAACACTGTTGTTTTGTAAGTAC
Motif Score 2.168095238
Cell/Tissue List hESC-HEK293T
Seq Type List MAZTER-seq
Transcript ID List ENST00000403290.5; ENST00000403482.7; ENST00000401424.5; ENST00000529390.1; ENST00000524392.5; ENST00000472842.1; ENST00000389707.8; ENST00000403510.7
External Link RMBase: m6A_site_132533
mod ID: M6ASITE004222 Click to Show/Hide the Full List
mod site chr11:13376704-13376705:+ [6]
Sequence AGCATCCCCCCACAGCATGGACAGCATGCTGCCCTCTGGAG
Motif Score 3.643047619
Cell/Tissue List HEK293T
Seq Type List DART-seq
Transcript ID List ENST00000403510.7; ENST00000403290.5; ENST00000472842.1; ENST00000524392.5; ENST00000401424.5; ENST00000529390.1; ENST00000389707.8; ENST00000403482.7
External Link RMBase: m6A_site_132534
mod ID: M6ASITE004223 Click to Show/Hide the Full List
mod site chr11:13386710-13386711:+ [9]
Sequence CTCTTGGAAGCAGATGCTGGACTGGGTGGCCCTGTTGACTT
Motif Score 4.065041667
Cell/Tissue List HeLa; HepG2; A549; HEK293A-TOA; TIME
Seq Type List m6A-seq; MeRIP-seq
Transcript ID List ENST00000524392.5; ENST00000389707.8; ENST00000403510.7; ENST00000401424.5; ENST00000472842.1; ENST00000403482.7; ENST00000403290.5
External Link RMBase: m6A_site_132535
mod ID: M6ASITE004224 Click to Show/Hide the Full List
mod site chr11:13386736-13386737:+ [6]
Sequence TGGCCCTGTTGACTTTAGTGACTTGCCATGGCCGCTGTAAA
Motif Score 3.28175
Cell/Tissue List HEK293T
Seq Type List DART-seq
Transcript ID List ENST00000524392.5; ENST00000401424.5; ENST00000389707.8; ENST00000403510.7; ENST00000403290.5; ENST00000472842.1; ENST00000403482.7
External Link RMBase: m6A_site_132536
mod ID: M6ASITE004225 Click to Show/Hide the Full List
mod site chr11:13386756-13386757:+ [9]
Sequence ACTTGCCATGGCCGCTGTAAACACTACATGTTGCTTTGGCA
Motif Score 2.20572619
Cell/Tissue List HeLa; HEK293T; HepG2; A549; GM12878; HEK293A-TOA; MSC; TIME; iSLK
Seq Type List m6A-seq; MeRIP-seq
Transcript ID List ENST00000403482.7; ENST00000403510.7; ENST00000401424.5; ENST00000389707.8; ENST00000524392.5; ENST00000472842.1; ENST00000403290.5
External Link RMBase: m6A_site_132537
mod ID: M6ASITE004226 Click to Show/Hide the Full List
mod site chr11:13387107-13387108:+ [4]
Sequence TTCAGATGTATGGTGTTTTTACACTACAAAGAAGTCCCCCA
Motif Score 2.07285119
Cell/Tissue List hESC-HEK293T
Seq Type List MAZTER-seq
Transcript ID List ENST00000389707.8; ENST00000401424.5; ENST00000403510.7; ENST00000524392.5; ENST00000472842.1; ENST00000403482.7; ENST00000403290.5
External Link RMBase: m6A_site_132538
mod ID: M6ASITE004227 Click to Show/Hide the Full List
mod site chr11:13387112-13387113:+ [4]
Sequence ATGTATGGTGTTTTTACACTACAAAGAAGTCCCCCATGTGG
Motif Score 2.078666667
Cell/Tissue List hESC-HEK293T
Seq Type List MAZTER-seq
Transcript ID List ENST00000403482.7; ENST00000403510.7; ENST00000401424.5; ENST00000389707.8; ENST00000403290.5; ENST00000524392.5; ENST00000472842.1
External Link RMBase: m6A_site_132539